Ultragenyx Pharmaceutical
RARE
$60.42
Share price
2.53%
Change (1 day)
-23.43%
Change (1 year)
Categories
Ultragenyx Pharmaceutical (RARE) - Total assets
Total assets on the balance sheet as of December 2024 : NZ$2.61 Billion
According to Ultragenyx Pharmaceutical's latest financial reports the company's total assets are NZ$2.61 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Ultragenyx Pharmaceutical - Total assets on balance sheet (from 2012 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | NZ$2.66 B | 13.07% |
| 2023-12-31 | NZ$2.35 B | -3.14% |
| 2022-12-31 | NZ$2.43 B | 9.21% |
| 2021-12-31 | NZ$2.22 B | -8.6% |
| 2020-12-31 | NZ$2.43 B | 44.64% |
| 2019-12-31 | NZ$1.68 B | 57.17% |
| 2018-12-31 | NZ$1.07 B | 55.24% |
| 2017-12-31 | NZ$0.69 B | -11.46% |
| 2016-12-31 | NZ$0.78 B | -4.54% |
| 2015-12-31 | NZ$0.81 B | 223.58% |
| 2014-12-31 | NZ$0.25 B | 248.09% |
| 2013-12-31 | NZ$72.58 M | -32.39% |
| 2012-12-31 | NZ$0.10 B | 590.8% |
| 2011-12-31 | NZ$15.54 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | NZ$12.17 B | 364.86% | 🇺🇸 USA |
 | NZ$1.36 B | -47.78% | 🇺🇸 USA |
 | NZ$0.59 B | -77.13% | 🇺🇸 USA |
 | NZ$0.51 B | -80.15% | 🇺🇸 USA |